Hanna Panfilova
Unknown Affiliation

Published : 2 Documents Claim Missing Document
Claim Missing Document
Check
Articles

Found 2 Documents
Search

Results of the Comparative Analysis of the Willingness-To-Pay Threshold Indicators for Introduction of Innovative Technologies in Healthcare Calculated on the Basis of the Purchasing Power Parity of the Population in Ukraine, Azerbaijan, Armenia, and Georgia Hanna Panfilova
Journal of Global Pharma Technology Volume 12 Issue 06 (2020) June 2020
Publisher : Journal of Global Pharma Technology

Show Abstract | Download Original | Original Source | Check in Google Scholar | Full PDF (466.191 KB)

Abstract

Objective: To conduct a comparative analysis of the dynamics of changes in the willingness-to-pay indicators concerning introduction of the innovative technology in the national healthcare systems of Azerbaijan, Armenia, Georgia and Ukraine. Methods: The studies used the “Willingness-to-pay” calculation method proposed by the WHO Commission on Health Macroeconomics and Economics. Calculation and comparison of willingness-to-pay indicators in the reference countries was carried out on the basis of the purchasing power parity (PPP) of the population. Results: It was found that during 2010-2017 Azerbaijan consistently held the leading position when introducing the innovative technology in healthcare by the willingness-to-pay value. By the average value of willingness-to-pay indicators (in 2010-2017) the reference countries were distributed in ascending order of indicators in the following way: Armenia (24, 28 USD Thousand); Ukraine (25,02 USD Thousand); Georgia (26,30 USD Thousand); Azerbaijan (50,61 USD Thousand). Therefore, the average value of the willingness-to-pay indicator in Azerbaijan was approximately twice as much as in other reference countries. Іn ascending order of the average growth rate values (%) of the willingness-to-pay indicator the countries were distributed as follows: Azerbaijan (101.69%); Ukraine (102.02%); Armenia (105.4%); Georgia (107.2%). Azerbaijan demonstrated the highest willingness-to-pay indicators, but it showed the lowest average growth rates (%) within 2010-2017. The highest growth rate (%) of the willingness-to-pay indicator was observed in Georgia. Conclusion: The results of the studies conducted can be used to form an objective assessment of the threshold values of national healthcare systems in Azerbaijan, Armenia, Georgia and Ukraine. Keywords: Innovative drug, Innovative health technology, Health technology assessment, Pharmaceutical provision of the population, Willingness-to-pay indicator.
Analysis of National Lists of Essential Medicines in Ukraine and the Who Model List of Essential Medicines in the Dynamics of the Year Hanna Panfilova
Journal of Global Pharma Technology Volume 10 Issue 12.
Publisher : Journal of Global Pharma Technology

Show Abstract | Download Original | Original Source | Check in Google Scholar

Abstract

The article contains results of dynamic of changes of National lists of Essential medicines in Ukraine during 2001-2017 and the WHO Model list of essential medicines (1977-2017). During a long period of time the WHO International concept of model list of essential medicines was considered to have a complicated dynamic of changes of medicines. In 1977 as compared to 2017, the number of medicines increased twice. Maximum increase (455 drugs) was observed in 2011 and minimum (204 drugs) – as in 1977. The fluctuation of chain increase of the number of medicines, which were included in the WHO Model list of essential medicines from –8,0% (2013) to +22,0% (1979). In the last edition (2017) the WHO Model list of essential medicines was changed significantly, which meet up-to-date requirements of practical medicines development, and the requirements of the society as to the efficiency of medical and pharmaceutical aid. A significant fluctuations of qualitative indicators of the WHO National list of Essential medicines in Ukraine (from 215 to 780 drugs) allow us to state about the absence of a systematic approach and a relevant policy to the implementation of the WHO International concept of Essential medicines in our country to practical health protection and pharmacy. Thus, in 2008 the number of medicines included in the WHO National list of Essential medicines had 780 names, which exceeded the number of medicines of existing edition of the WHO 15th Model list of essential medicines by 1,8. We proved that the last edition (2017) of the National list of Essential medicines, which was confirmed in Ukraine based on the government program “Available medicines”, meets international requirements.Keywords: National Drug Policy, National list of Essential Medicines of Ukraine, Model list of Еessential medicines, рarmaceutical market of Ukraine, Ukraine, World Health Organization.